Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
311.71
-11.51 (-3.56%)
Aug 13, 2025, 10:57 AM EDT
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,189
Profits / Employee
$114,831
Market Cap
265.71B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
Roche Holding AG News
- 1 day ago - Pilatus Biosciences Announces Clinical Trial Collaboration with Roche to Evaluate PLT012 in First-in-Human Study in Hepatocellular Carcinoma - Business Wire
- 3 days ago - Roche, Novartis due to meet Swiss govt. amid Trump’s tariff threats: Reuters - Seeking Alpha
- 3 days ago - Swiss government to meet pharma firms to discuss US tariffs - Reuters
- 4 days ago - Swiss Government Engages Roche and Novartis on U.S. Tariff Impact - GuruFocus
- 10 days ago - Roche gets FDA clearance for respiratory test to detect viruses - Seeking Alpha
- 13 days ago - Roche's Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD) - GlobeNewsWire
- 13 days ago - Genentech's Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD) - Business Wire
- 15 days ago - Trump's pharmaceutical tariffs could affect some drugmakers more than others - CNBC